BlackRock’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.9M | Buy |
9,830,431
+3,072,502
| +45% | +$20M | ﹤0.01% | 2285 |
|
|
2025
Q1 | $53.6M | Buy |
6,757,929
+602,092
| +10% | +$4.77M | ﹤0.01% | 2321 |
|
|
2024
Q4 | $78M | Buy |
6,155,837
+1,446,675
| +31% | +$18.3M | ﹤0.01% | 2190 |
|
|
2024
Q3 | $65.6M | Buy |
4,709,162
+175,720
| +4% | +$2.45M | ﹤0.01% | 2290 |
|
|
2024
Q2 | $62.5M | Sell |
4,533,442
-497,993
| -10% | -$6.86M | ﹤0.01% | 2258 |
|
|
2024
Q1 | $83.1M | Sell |
5,031,435
-94,636
| -2% | -$1.56M | ﹤0.01% | 2134 |
|
|
2023
Q4 | $74.8M | Buy |
5,126,071
+437,637
| +9% | +$6.39M | ﹤0.01% | 2217 |
|
|
2023
Q3 | $57.5M | Buy |
4,688,434
+1,123,701
| +32% | +$13.8M | ﹤0.01% | 2293 |
|
|
2023
Q2 | $42.6M | Buy |
3,564,733
+1,306,238
| +58% | +$15.6M | ﹤0.01% | 2536 |
|
|
2023
Q1 | $30.2M | Sell |
2,258,495
-176,773
| -7% | -$2.36M | ﹤0.01% | 2708 |
|
|
2022
Q4 | $52.4M | Sell |
2,435,268
-105,967
| -4% | -$2.28M | ﹤0.01% | 2405 |
|
|
2022
Q3 | $50.9M | Buy |
2,541,235
+578,511
| +29% | +$11.6M | ﹤0.01% | 2397 |
|
|
2022
Q2 | $35.1M | Buy |
1,962,724
+799,808
| +69% | +$14.3M | ﹤0.01% | 2693 |
|
|
2022
Q1 | $11.5M | Buy |
1,162,916
+410,797
| +55% | +$4.08M | ﹤0.01% | 3426 |
|
|
2021
Q4 | $12.7M | Buy |
752,119
+230,846
| +44% | +$3.89M | ﹤0.01% | 3464 |
|
|
2021
Q3 | $12.4M | Buy |
521,273
+516,901
| +11,823% | +$12.3M | ﹤0.01% | 3525 |
|
|
2021
Q2 | $99K | Buy |
+4,372
| New | +$99K | ﹤0.01% | 4980 |
|